{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T06:31:39Z","timestamp":1773988299139,"version":"3.50.1"},"reference-count":77,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,11]],"date-time":"2026-01-11T00:00:00Z","timestamp":1768089600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2002830"],"award-info":[{"award-number":["2002830"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2008344"],"award-info":[{"award-number":["2008344"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2009851"],"award-info":[{"award-number":["2009851"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/j.neuropharm.2026.110833","type":"journal-article","created":{"date-parts":[[2026,1,10]],"date-time":"2026-01-10T07:37:49Z","timestamp":1768030669000},"page":"110833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Assessing the utility of the neurosteroid zuranolone to modify alcohol-related behaviours"],"prefix":"10.1016","volume":"288","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-4363-4217","authenticated-orcid":false,"given":"Lauren T.","family":"Ursich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amy J.","family":"Pearl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9867-3606","authenticated-orcid":false,"given":"Xavier J.","family":"Maddern","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6836-727X","authenticated-orcid":false,"given":"Andrew J.","family":"Lawrence","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9282-2743","authenticated-orcid":false,"given":"Leigh C.","family":"Walker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2026.110833_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2024.107454","article-title":"Efficacy of medications for the treatment of alcohol use disorder (AUD): a systematic review and meta-analysis considering baseline AUD severity","volume":"209","author":"Agabio","year":"2024","journal-title":"Pharmacol. Res."},{"issue":"39","key":"10.1016\/j.neuropharm.2026.110833_bib2","doi-asserted-by":"crossref","first-page":"14602","DOI":"10.1073\/pnas.0606544103","article-title":"Characterization of brain neurons that express enzymes mediating neurosteroid biosynthesis","volume":"103","author":"Agis-Balboa","year":"2006","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.neuropharm.2026.110833_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2020.108333","article-title":"Preclinical characterization of zuranolone (SAGE-217), a selective neuroactive steroid GABA(A) receptor positive allosteric modulator","volume":"181","author":"Althaus","year":"2020","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2026.110833_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2019.100207","article-title":"Realising the therapeutic potential of neuroactive steroid modulators of the GABA(A) receptor","volume":"12","author":"Belelli","year":"2020","journal-title":"Neurobiol. Stress"},{"key":"10.1016\/j.neuropharm.2026.110833_bib5","article-title":"The immediate and maintained effects of neurosteroids on GABAA receptors","volume":"24","author":"Belelli","year":"2022","journal-title":"Curr. Opin. Endocr. Metab. Res."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110833_bib6","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1111\/j.1530-0277.2010.01300.x","article-title":"Pregnenolone and ganaxolone reduce operant ethanol self-administration in alcohol-preferring p rats","volume":"34","author":"Besheer","year":"2010","journal-title":"Alcohol Clin. Exp. Res."},{"issue":"32","key":"10.1016\/j.neuropharm.2026.110833_bib7","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1093\/eurheartj\/ehab076","article-title":"How a new drug is born","volume":"42","author":"Caporali","year":"2021","journal-title":"Eur. Heart J."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00213-013-3276-5","article-title":"Neurosteroid interactions with synaptic and extrasynaptic GABA(A) receptors: regulation of subunit plasticity, phasic and tonic inhibition, and neuronal network excitability","volume":"230","author":"Carver","year":"2013","journal-title":"Psychopharmacology (Berl)"},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110833_bib9","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S2215-0366(19)30222-6","article-title":"Psychiatric comorbidities in alcohol use disorder","volume":"6","author":"Castillo-Carniglia","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110833_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/26331055251315488","article-title":"From pregnancy to postpartum: the dynamic reorganization of the maternal brain","volume":"20","author":"Chechko","year":"2025","journal-title":"Neurosci. Insights"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib11","doi-asserted-by":"crossref","DOI":"10.4088\/JCP.22m14445","article-title":"Zuranolone in major depressive disorder: results from MOUNTAIN-A phase 3, multicenter, double-blind, randomized, placebo-controlled trial","volume":"84","author":"Clayton","year":"2023","journal-title":"J. Clin. Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110833_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1176\/appi.ajp.20220459","article-title":"Zuranolone for the treatment of adults with major depressive disorder: a randomized, placebo-controlled phase 3 trial","volume":"180","author":"Clayton","year":"2023","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110833_bib13","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/j.jad.2024.01.268","article-title":"The magnitude and sustainability of treatment benefit of zuranolone on function and well-being as assessed by the SF-36 in adult patients with MDD and PPD: an integrated analysis of 4 randomized clinical trials","volume":"351","author":"Clayton","year":"2024","journal-title":"J. Affect. Disord."},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110833_bib14","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1001\/jamapsychiatry.2021.1559","article-title":"Effect of zuranolone vs placebo in postpartum depression: a randomized clinical trial","volume":"78","author":"Deligiannidis","year":"2021","journal-title":"JAMA Psychiatry"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110833_bib15","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1176\/appi.ajp.20220785","article-title":"Zuranolone for the treatment of postpartum depression","volume":"180","author":"Deligiannidis","year":"2023","journal-title":"Am. J. Psychiatr."},{"key":"10.1016\/j.neuropharm.2026.110833_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.jhealeco.2016.01.012","article-title":"Innovation in the pharmaceutical industry: new estimates of R&D costs","volume":"47","author":"DiMasi","year":"2016","journal-title":"J. Health Econ."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-00792-8","article-title":"The effect of age and sex on the expression of GABA signaling components in the human hippocampus and entorhinal cortex","volume":"11","author":"Ethiraj","year":"2021","journal-title":"Sci. Rep."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110833_bib18","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1097\/ADM.0000000000000133","article-title":"Moderators of varenicline treatment effects in a double-blind, placebo-controlled trial for alcohol dependence: an exploratory analysis","volume":"9","author":"Falk","year":"2015","journal-title":"J. Addiction Med."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib19","first-page":"2","article-title":"The endocrine system and alcohol drinking in females","volume":"40","author":"Finn","year":"2020","journal-title":"Alcohol Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuropharm.2023.109827","article-title":"Structure-activity relationships for locomotor stimulant effects and monoamine transporter interactions of substituted amphetamines and cathinones","volume":"245","author":"Fitzgerald","year":"2024","journal-title":"Neuropharmacology"},{"issue":"1\u20132","key":"10.1016\/j.neuropharm.2026.110833_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.drugalcdep.2008.03.021","article-title":"Ethanol intake patterns in female mice: influence of allopregnanolone and the inhibition of its synthesis","volume":"97","author":"Ford","year":"2008","journal-title":"Drug Alcohol Depend."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.bbr.2007.02.028","article-title":"Allopregnanolone influences the consummatory processes that govern ethanol drinking in C57BL\/6J mice","volume":"179","author":"Ford","year":"2007","journal-title":"Behav. Brain Res."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib23","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.alcohol.2005.11.002","article-title":"Treatment with and withdrawal from finasteride alter ethanol intake patterns in male C57BL\/6J mice: potential role of endogenous neurosteroids?","volume":"37","author":"Ford","year":"2005","journal-title":"Alcohol"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110833_bib24","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1097\/01.alc.0000179413.82308.6b","article-title":"Neurosteroid modulators of GABA(A) receptors differentially modulate ethanol intake patterns in male C57BL\/6J mice","volume":"29","author":"Ford","year":"2005","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib25","doi-asserted-by":"crossref","DOI":"10.2174\/011570159X328731250104062122","article-title":"Sex-dependent modulation of AMPA and GABAA receptors in response to perinatal stress: implications for cognitive and emotion-related behaviors","author":"Gaetano","year":"2025","journal-title":"Curr. Neuropharmacol."},{"issue":"12","key":"10.1016\/j.neuropharm.2026.110833_bib26","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1016\/S2215-0366(18)30337-7","article-title":"The global burden of disease attributable to alcohol and drug use in 195 countries and territories, 1990-2016: a systematic analysis for the global burden of Disease Study 2016","volume":"5","year":"2018","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/j.neuropharm.2026.110833_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2147\/NDT.S466260","article-title":"Clinical utility of zuranolone for postpartum depression: a narrative review","volume":"21","author":"Giannopoulos","year":"2025","journal-title":"Neuropsychiatric Dis. Treat."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib28","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1046\/j.1460-9568.2003.02479.x","article-title":"Sex differences in anxiety, sensorimotor gating and expression of the alpha4 subunit of the GABAA receptor in the amygdala after progesterone withdrawal","volume":"17","author":"Gulinello","year":"2003","journal-title":"Eur. J. Neurosci."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110833_bib29","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1056\/NEJMoa1815981","article-title":"Trial of SAGE-217 in patients with major depressive disorder","volume":"381","author":"Gunduz-Bruce","year":"2019","journal-title":"N. Engl. J. Med."},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110833_bib30","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/j.1530-0277.1998.tb03708.x","article-title":"The reinforcing effects of ethanol are altered by the endogenous neurosteroid, allopregnanolone","volume":"22","author":"Janak","year":"1998","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib31","article-title":"Comorbid posttraumatic stress disorder and alcohol use disorder in low- and middle-income countries: a narrative review","volume":"10","author":"Kaysen","year":"2023","journal-title":"Glob. Ment. Health (Camb)"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib32","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1186\/s12913-022-08272-z","article-title":"Drug repurposing: a systematic review on root causes, barriers and facilitators","volume":"22","author":"Krishnamurthy","year":"2022","journal-title":"BMC Health Serv. Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib33","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/170435","article-title":"Plasticity of GABAA receptors during pregnancy and postpartum period: from gene to function","volume":"2015","author":"Licheri","year":"2015","journal-title":"Neural Plast."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110833_bib34","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1177\/0269881112444324","article-title":"BAP updated guidelines: evidence-based guidelines for the pharmacological management of substance abuse, harmful use, addiction and comorbidity: recommendations from BAP","volume":"26","author":"Lingford-Hughes","year":"2012","journal-title":"J. Psychopharmacol."},{"issue":"19","key":"10.1016\/j.neuropharm.2026.110833_bib35","doi-asserted-by":"crossref","first-page":"3226","DOI":"10.1111\/bph.13843","article-title":"Neurosteroid biosynthesis down-regulation and changes in GABA(A) receptor subunit composition: a biomarker axis in stress-induced cognitive and emotional impairment","volume":"174","author":"Locci","year":"2017","journal-title":"Br. J. Pharmacol."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110833_bib36","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.1523\/JNEUROSCI.6256-11.2012","article-title":"Corticotropin releasing factor signaling in the central amygdala is recruited during binge-like ethanol consumption in C57BL\/6J mice","volume":"32","author":"Lowery-Gionta","year":"2012","journal-title":"J. Neurosci."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110833_bib37","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1210\/jcem.85.7.6675","article-title":"Serum allopregnanolone levels in pregnant women: changes during pregnancy, at delivery, and in hypertensive patients","volume":"85","author":"Luisi","year":"2000","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110833_bib38","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/mp.2010.120","article-title":"The GABAergic deficit hypothesis of major depressive disorder","volume":"16","author":"Luscher","year":"2011","journal-title":"Mol. Psychiatr."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib39","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1038\/s41386-023-01712-2","article-title":"Cocaine and amphetamine regulated transcript (CART) mediates sex differences in binge drinking through central taste circuits","volume":"49","author":"Maddern","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"9","key":"10.1016\/j.neuropharm.2026.110833_bib40","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqae088","article-title":"Sex differences in alcohol use: is it all about hormones?","volume":"165","author":"Maddern","year":"2024","journal-title":"Endocrinology"},{"key":"10.1016\/j.neuropharm.2026.110833_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.3389\/fncel.2014.00157","article-title":"Stress-induced plasticity of GABAergic inhibition","volume":"8","author":"Maguire","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib42","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.neuron.2008.06.019","article-title":"GABA(A)R plasticity during pregnancy: relevance to postpartum depression","volume":"59","author":"Maguire","year":"2008","journal-title":"Neuron"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib43","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41386-023-01626-z","article-title":"Neurosteroids: mechanistic considerations and clinical prospects","volume":"49","author":"Maguire","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110833_bib44","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40273-021-01031-8","article-title":"What are the economic costs to society attributable to alcohol use? A systematic review and modelling study","volume":"39","author":"Manthey","year":"2021","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/j.neuropharm.2026.110833_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1298359","article-title":"Zuranolone - synthetic neurosteroid in treatment of mental disorders: narrative review","volume":"14","author":"Marecki","year":"2023","journal-title":"Front. Psychiatr."},{"issue":"18","key":"10.1016\/j.neuropharm.2026.110833_bib46","doi-asserted-by":"crossref","first-page":"7810","DOI":"10.1021\/acs.jmedchem.7b00846","article-title":"Neuroactive steroids. 2. 3alpha-Hydroxy-3beta-methyl-21-(4-cyano-1H-pyrazol-1'-yl)-19-nor-5beta-pregnan-20-one (SAGE-217): a clinical next generation neuroactive steroid positive allosteric modulator of the (gamma-Aminobutyric Acid)(A) receptor","volume":"60","author":"Martinez Botella","year":"2017","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2026.110833_bib47","article-title":"Performing vaginal lavage, crystal violet staining, and vaginal cytological evaluation for mouse estrous cycle staging identification","volume":"67","author":"McLean","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2026.110833_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.ynstr.2020.100212","article-title":"Allopregnanolone in postpartum depression: role in pathophysiology and treatment","volume":"12","author":"Meltzer-Brody","year":"2020","journal-title":"Neurobiol. Stress"},{"issue":"2","key":"10.1016\/j.neuropharm.2026.110833_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.4103\/0976-0105.177703","article-title":"A simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J. Basic Clin. Pharm."},{"key":"10.1016\/j.neuropharm.2026.110833_bib50","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.psyneuen.2017.02.012","article-title":"Lower allopregnanolone during pregnancy predicts postpartum depression: an exploratory study","volume":"79","author":"Osborne","year":"2017","journal-title":"Psychoneuroendocrinology"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib51","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/s41386-023-01721-1","article-title":"Novel neurosteroid therapeutics for post-partum depression: perspectives on clinical trials, program development, active research, and future directions","volume":"49","author":"Patterson","year":"2024","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib52","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/nrd3078","article-title":"How to improve R&D productivity: the pharmaceutical industry's grand challenge","volume":"9","author":"Paul","year":"2010","journal-title":"Nat. Rev. Drug Discov."},{"issue":"6","key":"10.1016\/j.neuropharm.2026.110833_bib53","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1096\/fasebj.6.6.1347506","article-title":"Neuroactive steroids","volume":"6","author":"Paul","year":"1992","journal-title":"FASEB J."},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110833_bib54","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1111\/j.1530-0277.1997.tb03824.x","article-title":"Naltrexone effects on ethanol drinking acquisition and on established ethanol consumption in C57BL\/6J mice","volume":"21","author":"Phillips","year":"1997","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib55","doi-asserted-by":"crossref","first-page":"446","DOI":"10.3389\/fphar.2016.00446","article-title":"Sex-dependent anti-stress effect of an alpha5 subunit containing GABA(A) receptor positive allosteric modulator","volume":"7","author":"Piantadosi","year":"2016","journal-title":"Front. Pharmacol."},{"issue":"14","key":"10.1016\/j.neuropharm.2026.110833_bib56","doi-asserted-by":"crossref","first-page":"5567","DOI":"10.1073\/pnas.0801853105","article-title":"Decreased corticolimbic allopregnanolone expression during social isolation enhances contextual fear: a model relevant for posttraumatic stress disorder","volume":"105","author":"Pibiri","year":"2008","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib57","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/j.1365-2826.2011.02234.x","article-title":"Up-regulation of neurosteroid biosynthesis as a pharmacological strategy to improve behavioural deficits in a putative mouse model of post-traumatic stress disorder","volume":"24","author":"Pinna","year":"2012","journal-title":"J. Neuroendocrinol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110833_bib58","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1038\/s41593-024-01741-0","article-title":"Neuroanatomical changes observed over the course of a human pregnancy","volume":"27","author":"Pritschet","year":"2024","journal-title":"Nat. Neurosci."},{"issue":"3\u20104","key":"10.1016\/j.neuropharm.2026.110833_bib59","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1369-1600.2008.00102.x","article-title":"Preclinical study: baclofen reduces ethanol intake in high\u2010alcohol\u2010drinking University of Chile bibulous rats","volume":"3","author":"Quintanilla","year":"2008","journal-title":"Addict. Biol."},{"issue":"11","key":"10.1016\/j.neuropharm.2026.110833_bib60","doi-asserted-by":"crossref","first-page":"1994","DOI":"10.1111\/j.1530-0277.2011.01551.x","article-title":"Alteration of ethanol drinking in mice via modulation of the GABA(A) receptor with ganaxolone, finasteride, and gaboxadol","volume":"35","author":"Ramaker","year":"2011","journal-title":"Alcohol Clin. Exp. Res."},{"key":"10.1016\/j.neuropharm.2026.110833_bib61","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/B978-0-444-53630-3.00008-7","article-title":"Neurosteroids: endogenous role in the human brain and therapeutic potentials","volume":"186","author":"Reddy","year":"2010","journal-title":"Prog. Brain Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib62","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S0091-3057(98)00062-8","article-title":"Acute toluene induces biphasic changes in rat spontaneous locomotor activity which are blocked by remoxipride","volume":"62","author":"Riegel","year":"2009","journal-title":"Pharmacol. Biochem. Behav."},{"issue":"7","key":"10.1016\/j.neuropharm.2026.110833_bib63","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/0269881117699618","article-title":"Effects of varenicline on alcohol self-administration and craving in drinkers with depressive symptoms","volume":"31","author":"Roberts","year":"2017","journal-title":"J. Psychopharmacol."},{"key":"10.1016\/j.neuropharm.2026.110833_bib64","series-title":"Zurzuvae (zuranolone) [package insert]","year":"2023"},{"issue":"4","key":"10.1016\/j.neuropharm.2026.110833_bib65","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1007\/s00213-002-1123-1","article-title":"Alteration of voluntary ethanol and saccharin consumption by the neurosteroid allopregnanolone in mice","volume":"162","author":"Sinnott","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110833_bib66","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/j.1471-4159.2009.06539.x","article-title":"Stress and GABAA receptors","volume":"112","author":"Skilbeck","year":"2010","journal-title":"J. Neurochem."},{"issue":"10","key":"10.1016\/j.neuropharm.2026.110833_bib67","doi-asserted-by":"crossref","first-page":"3409","DOI":"10.1523\/JNEUROSCI.21-10-03409.2001","article-title":"Loss of the major GABA(A) receptor subtype in the brain is not lethal in mice","volume":"21","author":"Sur","year":"2001","journal-title":"J. Neurosci."},{"key":"10.1016\/j.neuropharm.2026.110833_bib68","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.jpsychires.2021.04.004","article-title":"Prevalence and incidence of postpartum depression and environmental factors: the IGEDEPP cohort","volume":"138","author":"Tebeka","year":"2021","journal-title":"J. Psychiatr. Res."},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib69","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00213-005-0148-7","article-title":"Pharmacokinetic and behavioral effects of allopregnanolone in healthy women","volume":"186","author":"Timby","year":"2006","journal-title":"Psychopharmacology (Berl)"},{"issue":"3","key":"10.1016\/j.neuropharm.2026.110833_bib70","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S0022-3565(25)24172-6","article-title":"Steroid anesthetics and naturally occurring analogs modulate the gamma-aminobutyric acid receptor complex at a site distinct from barbiturates","volume":"248","author":"Turner","year":"1989","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2026.110833_bib71","first-page":"1","article-title":"Investigational drug therapies in phase I and phase II clinical trials for alcohol use disorders","author":"Walker","year":"2018","journal-title":"Expet Opin. Invest. Drugs"},{"issue":"5","key":"10.1016\/j.neuropharm.2026.110833_bib72","doi-asserted-by":"crossref","first-page":"886","DOI":"10.2174\/1570159X19666211202150041","article-title":"Neurosteroid modulation of GABA(A) receptor function by independent action at multiple specific binding sites","volume":"20","author":"Wang","year":"2022","journal-title":"Curr. Neuropharmacol."},{"key":"10.1016\/j.neuropharm.2026.110833_bib73","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2024.106485","article-title":"Neurosteroids: a potential target for neuropsychiatric disorders","volume":"239","author":"Wang","year":"2024","journal-title":"J. Steroid Biochem. Mol. Biol."},{"key":"10.1016\/j.neuropharm.2026.110833_bib74","series-title":"Global Status Report on Alcohol and Health and Treatment of Substance Use Disorders","year":"2024"},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib75","doi-asserted-by":"crossref","first-page":"65","DOI":"10.55782\/ane-2012-1881","article-title":"Psychomotor and rewarding properties of the neurosteroids dehydroepiandrosterone sulphate and androsterone: effects on monoamine and steroid metabolism","volume":"72","author":"Zajda","year":"2012","journal-title":"Acta Neurobiol. Exp."},{"issue":"1","key":"10.1016\/j.neuropharm.2026.110833_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.xpro.2021.100330","article-title":"Method for voluntary oral administration of drugs in mice","volume":"2","author":"Zhang","year":"2021","journal-title":"STAR Protoc."},{"key":"10.1016\/j.neuropharm.2026.110833_bib77","unstructured":"Victoria., 2020. Prevention of Cruelty to Animals Act 1986. No. 096, https:\/\/www.legislation.vic.gov.au\/."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390826000067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T04:51:27Z","timestamp":1773982287000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390826000067"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5]]},"references-count":77,"alternative-id":["S0028390826000067"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110833","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Assessing the utility of the neurosteroid zuranolone to modify alcohol-related behaviours","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2026.110833","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110833"}}